-
Qiushui
He,
J.
Mertsola
(2008)
Factors contributing to pertussis resurgence.
Future microbiology, 3 3
-
B.
Berg,
S.
David,
H.
Beekhuizen,
F.
Mooi,
R.
Furth
(2000)
Protection and humoral immune responses against Bordetella pertussis infection in mice immunized with acellular or cellular pertussis immunogens.
Vaccine, 19 9-10
-
R.
Kedl,
W.
Rees,
David
Hildeman,
B.
Schaefer,
T.
Mitchell,
J.
Kappler,
P.
Marrack
(2000)
T Cells Compete for Access to Antigen-Bearing Antigen-Presenting Cells
The Journal of Experimental Medicine, 192
-
K.
Mills
(2001)
Immunity to Bordetella pertussis.
Microbes and infection, 3 8
-
Ross
Andrews,
A.
Herceg,
Christine
Roberts
(1997)
Pertussis notifications in Australia, 1991 to 1997.
Communicable diseases intelligence, 21 11
-
E.
Hewlett,
K.
Edwards
(2005)
Clinical practice. Pertussis--not just for kids.
The New England journal of medicine, 352 12
-
Hongjin
Bian,
J.
Reidhaar-Olson,
J.
Hammer
(2003)
The use of bioinformatics for identifying class II-restricted T-cell epitopes.
Methods, 29 3
-
G.
DeSerres,
N.
Boulianne,
M.
DouvilleFradet,
Bernard
Duval
(1995)
Pertussis in Quebec: ongoing epidemic since the late 1980s.
Canada communicable disease report = Releve des maladies transmissibles au Canada, 21 5
-
Hongjin
Bian,
J.
Hammer
(2004)
Discovery of promiscuous HLA-II-restricted T cell epitopes with TEPITOPE.
Methods, 34 4
-
J.
Parkhill,
M.
Sebaihia,
A.
Preston,
L.
Murphy,
N.
Thomson,
D.
Harris,
M.
Holden,
C.
Churcher,
S.
Bentley,
K.
Mungall,
A.
Cerdeño-Tárraga,
L.
Temple,
K.
James,
B.
Harris,
M.
Quail,
M.
Achtman,
R.
Atkin,
S.
Baker,
D.
Basham,
N.
Bason,
Inna
Cherevach,
T.
Chillingworth,
M.
Collins,
A.
Cronin,
P.
Davis,
J.
Doggett,
T.
Feltwell,
A.
Goble,
N.
Hamlin,
H.
Hauser,
S.
Holroyd,
K.
Jagels,
S.
Leather,
S.
Moule,
Halina
Norberczak,
S.
O'neil,
D.
Ormond,
C.
Price,
E.
Rabbinowitsch,
S.
Rutter,
M.
Sanders,
D.
Saunders,
K.
Seeger,
S.
Sharp,
M.
Simmonds,
J.
Skelton,
R.
Squares,
S.
Squares,
K.
Stevens,
L.
Unwin,
S.
Whitehead,
B.
Barrell,
D.
Maskell
(2003)
Comparative analysis of the genome sequences of Bordetella pertussis, Bordetella parapertussis and Bordetella bronchiseptica
Nature Genetics, 35
-
E.
Cahill,
D.
O’hagan,
Lisbeth
Illum,
A.
Barnard,
Kingston
Mills,
K.
Redhead
(1995)
Immune responses and protection against Bordetella pertussis infection after intranasal immunization of mice with filamentous haemagglutinin in solution or incorporated in biodegradable microparticles.
Vaccine, 13 5
-
H.
Cohen
(2005)
Development of pertussis vaccine production and control in the National Institute of Public Health in the Netherlands during the years 1950–1962
Antonie van Leeuwenhoek, 29
-
M.
Magistris,
M.
Romano,
A.
Bartoloni,
R.
Rappuoli,
A.
Tagliabue
(1989)
Human T cell clones define S1 subunit as the most immunogenic moiety of pertussis toxin and determine its epitope map
The Journal of Experimental Medicine, 169
-
N.
Crowcroft,
R.
Pebody
(2006)
Recent developments in pertussis
The Lancet, 367
-
C.
Kirschning,
R.
Schumann
(2002)
TLR2: cellular sensor for microbial and endogenous molecular patterns.
Current topics in microbiology and immunology, 270
-
Y.
Sato,
J.
Cowell,
H.
Sato,
D.
Burstyn,
C.
Manclark
(1983)
Separation and purification of the hemagglutinins from Bordetella pertussis
Infection and Immunity, 41
-
M.
Hijnen,
P.
Gageldonk,
G.
Berbers,
Tiest
Woerkom,
F.
Mooi
(2005)
The Bordetella pertussis virulence factor P.69 pertactin retains its immunological properties after overproduction in Escherichia coli.
Protein expression and purification, 41 1
-
(2002)
Nanoscale LC-MS: technical design and applications to peptide and B. pertussis MHC Class II Epitope Repertoire May 2014 Volume 21 Number 5 cvi.asm.org 649 protein analysis
-
Mark
Ryan,
G.
Murphy,
Leif
Gothefors,
Lennart
Nilsson,
J.
Storsaeter,
Kingston
Mills
(1997)
Bordetella pertussis respiratory infection in children is associated with preferential activation of type 1 T helper cells.
The Journal of infectious diseases, 175 5
-
H.
Melker,
M.
Spaendonck,
H.
Rümke,
J.
Wijngaarden,
F.
Mooi,
J.
Schellekens
(1997)
Pertussis in The Netherlands: an outbreak despite high levels of immunization with whole-cell vaccine.
Emerging Infectious Diseases, 3
-
Chopie
Hassan,
Michel
Kester,
Arnoud
Ru,
P.
Hombrink,
J.
Drijfhout,
H.
Nijveen,
Jack
Leunissen,
M.
Heemskerk,
J.
Falkenburg,
P.
Veelen
(2013)
The Human Leukocyte Antigen–presented Ligandome of B Lymphocytes*
Molecular & Cellular Proteomics, 12
-
B.
Waterbeemd,
M.
Streefland,
J.
Pennings,
L.
Pol,
C.
Beuvery,
J.
Tramper,
D.
Martens
(2009)
Gene‐expression‐based quality scores indicate optimal harvest point in Bordetella pertussis cultivation for vaccine production
Biotechnology and Bioengineering, 103
-
P.
Stefanelli,
C.
Fazio,
G.
Fedele,
F.
Spensieri,
C.
Ausiello,
P.
Mastrantonio
(2009)
A natural pertactin deficient strain of Bordetella pertussis shows improved entry in human monocyte-derived dendritic cells.
The new microbiologica, 32 2
-
D.
Guris,
P.
Strebel,
B.
Bardenheier,
M.
Brennan,
R.
Tachdjian,
Evelyn
Finch,
M.
Wharton,
J.
Livengood
(1999)
Changing epidemiology of pertussis in the United States: increasing reported incidence among adolescents and adults, 1990-1996.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 28 6
-
C.
Ausiello,
R.
Lande,
A.
Sala,
F.
Urbani,
Antonio
Cassone
(1998)
Cell-mediated immune response of healthy adults to Bordetella pertussis vaccine antigens.
The Journal of infectious diseases, 178 2
-
M.
Magistris,
M.
Romano,
S.
Nuti,
R.
Rappuoli,
A.
Tagliabue
(1988)
Dissecting human T cell responses against Bordetella species
The Journal of Experimental Medicine, 168
-
P.
Mobberley-Schuman,
A.
Weiss
(2005)
Influence of CR3 (CD11b/CD18) Expression on Phagocytosis of Bordetella pertussis by Human Neutrophils
Infection and Immunity, 73
-
J.
Poolman,
B.
Kuipers,
M.
Vogel,
H.
Hamstra,
J.
Nagel
(1990)
Description of a hybridoma bank towards Bordetella pertussis toxin and surface antigens.
Microbial pathogenesis, 8 6
-
H.
Shim,
Jeoung
Kim,
Mi
Kim,
H.
Sim,
D.
Park,
J.
Sohn,
M.
Kim
(2009)
Legionella lipoprotein activates toll-like receptor 2 and induces cytokine production and expression of costimulatory molecules in peritoneal macrophages
Experimental & Molecular Medicine, 41
-
F.
Mascart,
V.
Verscheure,
A.
Malfroot,
M.
Hainaut,
D.
Piérard,
Stéphane
Temerman,
A.
Peltier,
A.
Debrie,
J.
Lévy,
G.
Giudice,
C.
Locht
(2003)
Bordetella pertussis Infection in 2-Month-Old Infants Promotes Type 1 T Cell Responses1
The Journal of Immunology, 170
-
J.
Cherry,
J.
Gornbein,
U.
Heininger,
K.
Stehr
(1998)
A search for serologic correlates of immunity to Bordetella pertussis cough illnesses.
Vaccine, 16 20
-
C.
Andreasen,
D.
Powell,
N.
Carbonetti
(2009)
Pertussis Toxin Stimulates IL-17 Production in Response to Bordetella pertussis Infection in Mice
PLoS ONE, 4
-
J.
Petersen,
Arne
Holm,
P.
Ibsen,
K.
Hasløv,
C.
Capiau,
I.
Heron
(1992)
Identification of human T-cell epitopes on the S4 subunit of pertussis toxin
Infection and Immunity, 60
-
M.
Tsan,
B.
Gao
(2009)
Heat shock proteins and immune system
Journal of Leukocyte Biology, 85
-
M.
Hirschfeld,
C.
Kirschning,
R.
Schwandner,
H.
Wesche,
J.
Weis,
R.
Wooten,
J.
Weis
(1999)
Cutting edge: inflammatory signaling by Borrelia burgdorferi lipoproteins is mediated by toll-like receptor 2.
Journal of immunology, 163 5
-
H.
Rammensee,
T.
Friede,
S.
Stevanović
(2004)
MHC ligands and peptide motifs: first listing
Immunogenetics, 41
-
M.
Leef,
K.
Elkins,
J.
Barbić,
R.
Shahin
(2000)
Protective Immunity to Bordetella pertussis Requires Both B Cells and Cd4+ T Cells for Key Functions Other than Specific Antibody Production
The Journal of Experimental Medicine, 191
-
S.
Peppoloni,
L.
Nencioni,
A.
Tommaso,
A.
Tagliabue,
P.
Parronchi,
S.
Romagnani,
R.
Rappuoli,
M.
Magistris
(1991)
Lymphokine secretion and cytotoxic activity of human CD4+ T-cell clones against Bordetella pertussis
Infection and Immunity, 59
-
H.
Brightbill,
D.
Libraty,
S.
Krutzik,
Ruey-Bing
Yang,
J.
Belisle,
Joshua
Bleharski,
M.
Maitland,
M.
Norgard,
S.
Plevy,
S.
Smale,
P.
Brennan,
B.
Bloom,
B.
Bloom,
P.
Godowski,
R.
Modlin
(1999)
Host defense mechanisms triggered by microbial lipoproteins through toll-like receptors.
Science, 285 5428
-
J.
Storsaeter,
H.
Hallander,
L.
Gustafsson,
P.
Olin
(1998)
Levels of anti-pertussis antibodies related to protection after household exposure to Bordetella pertussis.
Vaccine, 16 20
-
F.
Yarovinsky,
H.
Kanzler,
S.
Hieny,
R.
Coffman,
A.
Sher
(2006)
Toll-like receptor recognition regulates immunodominance in an antimicrobial CD4+ T cell response.
Immunity, 25 4
-
C.
Ausiello,
R.
Lande,
P.
Stefanelli,
C.
Fazio,
G.
Fedele,
R.
Palazzo,
F.
Urbani,
P.
Mastrantonio
(2003)
T-Cell Immune Response Assessment as a Complement to Serology and Intranasal Protection Assays in Determining the Protective Immunity Induced by Acellular Pertussis Vaccines in Mice
Clinical and Vaccine Immunology, 10
-
M.
Hijnen,
Richarda
Voer,
F.
Mooi,
R.
Schepp,
E.
Moret,
P.
Gageldonk,
G.
Smits,
G.
Berbers
(2007)
The role of peptide loops of the Bordetella pertussis protein P.69 pertactin in antibody recognition.
Vaccine, 25 31
-
Y.
Asai,
Y.
Makimura,
T.
Ogawa
(2007)
Toll-like receptor 2-mediated dendritic cell activation by a Porphyromonas gingivalis synthetic lipopeptide.
Journal of medical microbiology, 56 Pt 4
-
Hyun-ku
Lee,
Jongdae
Lee,
P.
Tobias
(2002)
Two Lipoproteins Extracted from Escherichia coli K-12 LCD25 Lipopolysaccharide Are the Major Components Responsible for Toll-Like Receptor 2-Mediated Signaling1
The Journal of Immunology, 168
-
B.
Mahon,
K.
Mills
(1999)
Interferon-γ mediated immune effector mechanisms against Bordetella pertussis
Immunology Letters, 68
-
W.
Eden,
R.
Zee,
B.
Prakken
(2005)
Heat-shock proteins induce T-cell regulation of chronic inflammation
Nature Reviews Immunology, 5
-
C.
Watts
(2012)
The endosome–lysosome pathway and information generation in the immune system☆
Biochimica et Biophysica Acta, 1824
-
V.
Dirix,
V.
Verscheure,
T.
Goetghebuer,
M.
Hainaut,
A.
Debrie,
C.
Locht,
F.
Mascart
(2009)
Monocyte-Derived Interleukin-10 Depresses the Bordetella pertussis- Specific Gamma Interferon Response in Vaccinated Infants
Clinical and Vaccine Immunology, 16
-
A.
Wendelboe,
A.
Rie,
S.
Salmaso,
J.
Englund
(2005)
Duration of Immunity Against Pertussis After Natural Infection or Vaccination
The Pediatric Infectious Disease Journal, 24
-
J.
Bass,
R.
Wittler
(1994)
Return of epidemic pertussis in the United States.
The Pediatric infectious disease journal, 13 5
-
R.
Sekura,
F.
Fish,
C.
Manclark,
B.
Meade,
Y.
Zhang
(1983)
Pertussis toxin. Affinity purification of a new ADP-ribosyltransferase.
The Journal of biological chemistry, 258 23
-
F.
Sallusto,
A.
Lanzavecchia
(1994)
Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor alpha
The Journal of Experimental Medicine, 179
-
M.
Magistris,
A.
Tommaso,
M.
Domenighini,
S.
Censini,
A.
Tagliabue,
J.
Oksenberg,
L.
Steinman,
A.
Judd,
D.
O'Sullivan,
R.
Rappuoli
(1992)
Interaction of the pertussis toxin peptide containing residues 30-42 with DR1 and the T-cell receptors of 12 human T-cell clones.
Proceedings of the National Academy of Sciences of the United States of America, 89 7
-
Kingston
Mills,
Amanda
Barnard,
'.
Watkins,
Keith
Redhead
(1993)
Cell-mediated immunity to Bordetella pertussis: role of Th1 cells in bacterial clearance in a murine respiratory infection model
Infection and Immunity, 61
-
G.
Berbers,
S.
Greeff,
F.
Mooi
(2009)
Improving pertussis vaccination
Human Vaccines, 5
-
H.
Meiring,
B.
Kuipers,
J.
Brink,
M.
Poelen,
H.
Timmermans,
Gino
Baart,
H.
Brugghe,
Joost
Schie,
C.
Boog,
A.
Jong,
C.
Els
(2005)
Mass Tag-Assisted Identification of Naturally Processed HLA Class II-Presented Meningococcal Peptides Recognized by CD4+ T Lymphocytes
The Journal of Immunology, 174
-
H.
Meiring,
E.
Heeft,
G.
Hove,
A.
Jong
(2002)
Nanoscale LC–MS(n): technical design and applications to peptide and protein analysis
Journal of Separation Science, 25
-
S.
Higgins,
A.
Jarnicki,
E.
Lavelle,
K.
Mills
(2006)
TLR4 Mediates Vaccine-Induced Protective Cellular Immunity to Bordetella pertussis: Role of IL-17-Producing T Cells1
The Journal of Immunology, 177
-
A.
Gzyl,
E.
Augustynowicz,
D.
Rabczenko,
G.
Gniadek,
J.
Ślusarczyk
(2004)
Pertussis in Poland.
International journal of epidemiology, 33 2
-
A.
Robinson,
A.
Gorringe,
S.
Funnell,
M.
Fernandez
(1989)
Serospecific protection of mice against intranasal infection with Bordetella pertussis.
Vaccine, 7 4
-
Patrick
Olin,
Hans
Hallander,
L.
Gustafsson,
E.
Reizenstein,
J.
Storsaeter
(2001)
How to make sense of pertussis immunogenicity data.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 33 Suppl 4
-
F.
Mascart,
M.
Hainaut,
A.
Peltier,
V.
Verscheure,
Jack
Levy,
Camille
Locht,
Camille
Locht
(2007)
Modulation of the infant immune responses by the first pertussis vaccine administrations.
Vaccine, 25 2
-
M.
Liang,
A.
Bagchi,
H.
Warren,
Megan
Tehan,
James
Trigilio,
Laura
Beasley‐Topliffe,
B.
Tesini,
J.
Lazzaroni,
M.
Fenton,
J.
Hellman
(2005)
Bacterial peptidoglycan-associated lipoprotein: a naturally occurring toll-like receptor 2 agonist that is shed into serum and has synergy with lipopolysaccharide.
The Journal of infectious diseases, 191 6
-
A.
Aliprantis,
Ruey-Bing
Yang,
M.
Mark,
Shelly
Suggett,
B.
Devaux,
J.
Radolf,
G.
Klimpel,
P.
Godowski,
A.
Zychlinsky
(1999)
Cell activation and apoptosis by bacterial lipoproteins through toll-like receptor-2.
Science, 285 5428
-
(2013)
Centres for Disease Control and Prevention
-
F.
Vermeulen,
V.
Verscheure,
E.
Damis,
D.
Vermeylen,
Gaëlle
Leloux,
V.
Dirix,
C.
Locht,
F.
Mascart
(2009)
Cellular Immune Responses of Preterm Infants after Vaccination with Whole-Cell or Acellular Pertussis Vaccines
Clinical and Vaccine Immunology, 17
-
B.
Mahon,
K.
Mills
(1999)
Interferon-gamma mediated immune effector mechanisms against Bordetella pertussis.
Immunology letters, 68 2-3
-
Thymidine incorporation was determined after 3 days of restimulation. Bars represent SI Ϯ SD from triplicate wells
-
Donato
Torre,
Giulio
Ferrario,
Giancarla
Bonetta,
Lorenza
Perversi,
R.
Tambini,
F.
Speranza
(1994)
Effects of recombinant human gamma interferon on intracellular survival of Bordetella pertussis in human phagocytic cells.
FEMS immunology and medical microbiology, 9 3
-
E.
Hewlett,
K.
Edwards
(2005)
Pertussis — Not Just for Kids
The New England Journal of Medicine, 352
-
(2013)
Notifiable diseases and mortality tables
-
R.
Stenger,
M.
Poelen,
E.
Moret,
B.
Kuipers,
S.
Bruijns,
P.
Hoogerhout,
M.
Hijnen,
A.
King,
F.
Mooi,
C.
Boog,
C.
Els
(2008)
Immunodominance in Mouse and Human CD4+ T-Cell Responses Specific for the Bordetella pertussis Virulence Factor P.69 Pertactin
Infection and Immunity, 77
-
R.
Godlewska,
K.
Wiśniewska,
Z.
Pietras,
E.
Jagusztyn-Krynicka
(2009)
Peptidoglycan-associated lipoprotein (Pal) of Gram-negative bacteria: function, structure, role in pathogenesis and potential application in immunoprophylaxis.
FEMS microbiology letters, 298 1
-
J.
Cherry
(2007)
Immunity to pertussis.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 44 10
-
Nicole
Guiso,
Elisabeth
Njamkepo,
F.
Sage,
Fred
Zepp,
C.
Meyer,
V.
Abitbol,
N.
Clyti,
S.
Chevallier
(2007)
Long-term humoral and cell-mediated immunity after acellular pertussis vaccination compares favourably with whole-cell vaccines 6 years after booster vaccination in the second year of life.
Vaccine, 25 8